Lilly v. Lemmon
Executive Summary
Newark, NJ, Federal Court ordered Lemmon to change the name of its generic propoxyphene napsylate/acetaminophen product from Provocetto name that is not confusingly similar to Lilly's DarvocetN. Lilly filed suit against Lemmon for trademark infringement June 3.